Outcomes of SGLT2i in Diabetic Kidney Disease: Is it all diabetes?

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Underlying mechanisms of nephroprotective effects with SGLT2i in CKD
Underlying mechanisms of nephroprotective effects with SGLT2i in CKD
SGLT2 inhibition in CKD: Discussing the key questions and evidence
Underlying mechanisms of nephroprotective effects with SGLT2i in CKD
- Paola Fioretto, MD
The clinical landscape of managing patients with CKD: Where are we now and what can we expect?
The clinical landscape of managing patients with CKD: Where are we now and what can we expect?
SGLT2 inhibition in CKD: Discussing the key questions and evidence
The clinical landscape of managing patients with CKD: Where are we now and what can we expect?
- Will Herrington, MD